medigraphic.com
ISSN 1995-9494 (Electronic)
Revista del Hospital Clínico Quirúrgico "Arnaldo Milián Castro"

2012, Number 2

<< Back Next >>

Acta Med Cent 2012; 6 (2)

Characterization of neoadjuvant and surgical treatment of locally advanced breast cancer

Ruiz LRM, de Armas PJI, Noda RA, Hernández MRM, Morales MR, Koné S

Language: Spanish
References: 17
Page:
PDF size: 62.51 Kb.


ABSTRACT

A descriptive, longitudinal and prospective study was conducted in order to evaluate the behavior of locally advanced breast cancer – according to its clinical, surgical and anatomopathologic features – in patients diagnosed with stage III and with indication of neoadjuvant chemotherapy at the Arnaldo Milian Castro and the Celestino Hernández Robau University Hospitals in Villa Clara during the period from January 2007 to December 2010. A sample of 52 patients was taken out of the total of cases with histological diagnosis. The data were obtained from the charge sheets of the statistics department, medical records and biopsy ballots, which were recorded in a form. It was found that locally advanced breast cancer predominated in ages from 40 to 59, located in the left breast and the upper outer quadrant, according to the histology of infiltrating ductal carcinoma. The neoadjuvant and anatomo-pathologic scheme most commonly used was adriamycin plus cyclophosphamide, with partial clinical and anatomo- pathologic response, although when adding Doxatacel the clinical response was better, resulting in a significant decrease in the post-neoadjuvant therapy and final anatomo-pathologic stages. The most common surgery performed was the modified radical mastectomy and axillary lymph node dissection. The breast-conserving surgery was conducted in a significant number of patients, where the most common contraindication was the presence of multicentric disease. It is recommended that new randomized trials are conducted in order to assess the neoadjuvant therapy and establish monitoring protocols to increase the candidates for breast-conserving surgery.


REFERENCES

  1. Greaves M. Cáncer el legado evolutivo [Internet] Barcelona: Editorial Crítica; 2004 [actualizado 4 Oct 2009; citado 28 Sep 2010]: [aprox. 10 p.]. Disponible en: http://books.google.co.ve/books!?i=Utl-5vGC JIC

  2. Avello E. Cáncer de mama. [Internet] España: Universidad de Oviedo; 2006 [actualizado 2 Jun 2010; citado 28 Sep 2010]:[aprox. 5 p.]. Disponible en: http://books.google.co.ve/books?id=hRVxLpoqDsUC

  3. Bermejo de las Heras B, Llunch Hernández A. Carcinoma inflamatorio de la mama. En: Alba Conejo E. Tratado de Oncología. 2da ed. Mallorca: Publicaciones Permanyer; 2009. p. 963-77.

  4. American Joint Comite on Cancer Breast. Cancer Staging Manual. 7ma ed. Philadelphia: Lippincott Williams and Wilkins; 2010. p. 347-77.

  5. Cáncer de mama, pulmón y próstata. Servicio Informativo de la Biblioteca Médica Nacional [Internet]. 2007 Ago [citado 14 Jul 2011];14(8):[aprox. 14 p.]. Disponible en: www.sld.cu/galerias/doc/sitios/bmn/b07v14n8.doc

  6. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics 2002. CA Cancer J Clin. 2005;55:74-108.

  7. Torre P, Guerra M, Galán Y. Incidencia y mortalidad por cáncer en la mujer cubana. Trienio 2000-2002. Rev Cubana Med. 2007;46(2):36-47.

  8. Mortalidad por cáncer de mama. Ministerio de Salud Pública. Dirección Nacional de Registros médicos y estadística de salud. Anuario estadístico de salud. Ciudad de la Habana: MINSAP; 2009.

  9. Cáncer de mama. Wikipedia, la enciclopedia libre-Epidemiología [Internet]. [actualizado 27 Sept 2010; citado 28 Sept 2011]:[aprox. 14 p]. Disponible en: http://es.wikipedia.org/wiki/C%C3%A1ncer_de_mama

  10. Buchholdz TA, Haffty Bg. Breast cancer: Locally Avanced and Recurrent Disease, Post mastectomy, Radiation, and Systemic Therapies. En: Halperin EC, Perez CA, Brady LW. Principles and practice of Radiation Oncology. 5ta ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 1292-314.

  11. Pérez AA, Estrada G, Pérez A. Métodos diagnósticos del cáncer de mama. Medicentro Electrón. 2008;12(1):32-48.

  12. El Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Reara FB, et al. Effects of young age at presentation on survival in breast cancer. BMC Cáncer. 2006;6:102- 94.

  13. Group EBCTC. Effects of radiotherapy and of differences in the extent of sugerí for early breast cancer on local recurrence and 15-years survival, an overview of the randomized trials. Lancet. 2006;366:2087-106.

  14. Lee MC, Newman LA. Tratamiento de las pacientes con cáncer de mama localmente avanzado. Surg Clin N Am. 2007(2):379-98.

  15. Strom EA, Wood WA, Katz A. Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiant Oncol Biol Phys. 2007;63:1508-13.

  16. Ruiz Lorente R, Rubio Hernández MC, Hernández Durán D, Tamayo Líen TG. Experiencia en mujeres con cáncer de mama durante un trienio. En: Consenso de tratamiento de Cáncer de mama. La Habana: INOR; 2007. p. 1-16.

  17. Von Minckwitz G, Blohmer JU, Raab G. In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early- state breast cancer: the Gepartrio pilot study. Ann Oncol. 2007;16(1):56-63.




2020     |     www.medigraphic.com